OncoSec Medical Inc (ONCSQ)

[chickpea598]

Thanks for posting. I think Oncosec's PISCES BORR will improve as more patients are evaluated and hit the 30% mark. The fact that the patients in PISCES are confirmed checkpoint failed patients is the key here (other company trials are likely skewing their actual response numbers higher). It is a salvage therapy and according to Oncosec is the quickest way to an approval. They have a good shot in my opinion. Other trials are starting as well and a new product candidate is coming soon makes Oncosec more interesting with regards to overall pipeline. TNBC could be a real winner too. About the STAT article, I remember AF pointing out in his previous article how significant the one confirmed checkpoint failed patient was. Now Oncosec is backing that previous data up with more responders (previously confirmed checkpoint failures) to TAVO/checkpoint....with time this therapy works for patients that have no other choice left.....so I would be positive about the current state of the PISCES trial.